Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

NCT00381719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG: AGN 203818
DRUG: AGN 203818
DRUG: AGN 203818
DRUG: placebo capsule

Sponsor

Allergan